Survival benefit in patients with native aortic regurgitation using a dedicated transcatherter valve vs non-dedicated transcatheter valves.
BACKGROUND Until recently, no standard of care has been established for patients with symptomatic native aortic regurgitation (AR) who are unsuitable for surgery. Transcatheter aortic valve implantation (TAVI) has been explored in this setting using off-label, non-dedicated valves originally designed for aortic stenosi...